Sanara MedTech Inc. to acquire Scendia Biologics, LLC
Sanara MedTech Inc. and Scendia Biologics, LLC entered the Exit Mode archive.
- Buyer
- Sanara MedTech Inc.
- Target
- Scendia Biologics, LLC
- Deal value
- USD 7,360,000
- Deal type
- strategic acquisition
Deals by sector
Track the healthcare deals published in the Exit Mode archive, with sourced facts, narrative context, and founder-relevant patterns.
Healthcare deals tell founders where buyers are concentrating, how fast consolidation is moving, and what strategic acquirers or PE firms appear willing to back. This archive view is built to make that signal easier to track without mixing sourced facts and editorial opinion into the same layer.
Sanara MedTech Inc. and Scendia Biologics, LLC entered the Exit Mode archive.
Cohen Enterprises, Inc. and Mangoceuticals, Inc. entered the Exit Mode archive.
Commodore Parent 2022, LLC and Convey Health Solutions Holdings, Inc. entered the Exit Mode archive.
GSK plc and Sierra Oncology, Inc. entered the Exit Mode archive.
Centene Corporation and Magellan Health, Inc. entered the Exit Mode archive.
iBio, Inc. and College Station Investors LLC entered the Exit Mode archive.
Fagron Compounding Services, LLC d/b/a Fagron Sterile Services and US Compounding, Inc. entered the Exit Mode archive.
DiaSorin Inc. and Luminex Corporation entered the Exit Mode archive.
Ventas, Inc. and New Senior Investment Group Inc. entered the Exit Mode archive.
Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc entered the Exit Mode archive.
Ligand Pharmaceuticals Incorporated and Pfenex Inc. entered the Exit Mode archive.
PUG LLC (viagogo) and StubHub business of eBay Inc entered the Exit Mode archive.
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
More M&A Tools
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Keep browsing